Suppr超能文献

临床医生对处于临床缓解期的系统性红斑狼疮患者背景治疗的管理方法:一项国际观察性调查结果

Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey.

作者信息

Ngamjanyaporn Pintip, McCarthy Eoghan M, Sergeant Jamie C, Reynolds John, Skeoch Sarah, Parker Benjamin, Bruce Ian N

机构信息

Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Lupus Sci Med. 2017 Jun 29;4(1):e000173. doi: 10.1136/lupus-2016-000173. eCollection 2017.

Abstract

BACKGROUND

The definition of remission in systemic lupus erythematosus (SLE) remains unclear, especially how background treatment should be interpreted.

OBJECTIVE

To determine preferences of clinicians in treatment of patients in clinical remission from SLE and to assess how previous severity, duration of remission and serology influence changes in treatment.

METHODS

We undertook an internet-based survey of clinicians managing patients with SLE. Case scenarios were constructed to reflect different remission states, previous organ involvement, serological abnormalities, duration of remission and current treatment (hydroxychloroquine (HCQ), steroids and/or immunosuppressive (ISS) agents).

RESULTS

130 clinicians from 30 countries were surveyed. The median (range) duration of practice and number of patients with SLE seen each month was 13 (2-42) years and 30 (2-200), respectively. Management decisions in all scenarios varied with greater caution in treatment reduction with shorter duration of remission, extent of serological abnormalities and previous disease severity. Even with mild disease, normal serology and a 5-year clinical remission, 113 (86.9%) clinicians continue to prescribe HCQ. Persistent abnormal serology in any scenario led to a reluctance to reduce or discontinue medications. Prescribing in remission, particularly of steroids and HCQ, varied significantly according to geographical location.

CONCLUSIONS

Clinicians preferences in withdrawing or reducing treatment in patients with SLE in clinical remission vary considerably. Serological abnormalities, previous disease severity and duration of remission all influence the decision to reduce treatment. It is unusual for clinicians to stop HCQ even after prolonged periods of clinical remission. Any definition(s) of remission needs to take into consideration such evidence on how maintenance treatments are managed.

摘要

背景

系统性红斑狼疮(SLE)缓解的定义仍不明确,尤其是背景治疗应如何解读。

目的

确定临床医生对SLE临床缓解患者的治疗偏好,并评估既往病情严重程度、缓解持续时间和血清学如何影响治疗变化。

方法

我们对管理SLE患者的临床医生进行了一项基于网络的调查。构建病例场景以反映不同的缓解状态、既往器官受累情况、血清学异常、缓解持续时间和当前治疗(羟氯喹(HCQ)、类固醇和/或免疫抑制剂(ISS))。

结果

对来自30个国家的130名临床医生进行了调查。临床医生的执业时间中位数(范围)和每月诊治的SLE患者数量分别为13(2 - 42)年和30(2 - 200)例。所有场景下的管理决策各不相同,缓解持续时间较短、血清学异常程度较高和既往疾病严重程度较高时,在减少治疗方面会更加谨慎。即使疾病较轻、血清学正常且有5年临床缓解期,仍有113名(86.9%)临床医生继续开具HCQ处方。在任何场景下,持续的血清学异常都会导致不愿减少或停用药物。缓解期的处方,尤其是类固醇和HCQ的处方,因地理位置而异。

结论

临床医生对临床缓解的SLE患者撤药或减药的偏好差异很大。血清学异常、既往疾病严重程度和缓解持续时间都会影响减药决策。即使经过长时间的临床缓解,临床医生停用HCQ的情况也很少见。缓解的任何定义都需要考虑关于维持治疗管理的此类证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c5b/5724341/8f15bc0c2837/lupus-2016-000173f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验